Skip to main content

Auszug

Die Zunahme chronischer Erkrankungen und die Veränderung der Alterspyramide führte zunächst v. a. in den somatisch ausgerichteten medizinischen Disziplinen zu einer zunehmenden Skepsis gegenüber der alleinigen Aussagekraft klassischer Bewertungskriterien medizinischer Interventionen. Innerhalb der psychiatrischen Forschung wurde ein erstes Bedürfnis nach subjektiven Ergebnisparametern durch die Enthospitalisierungswelle in den USA geweckt, bei der die gemeindepsychiatrische mit der stationären Versorgung verglichen wurde.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Bullinger M (1995) German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment. Soc Sci Med 41: 1359–1366

    CAS  Google Scholar 

  • Bullinger M (2002) Assessing health related quality of life in medicine. An overview over concepts, methods and applications in international research. Restor Neurol Neurosci 20: 93–101

    PubMed  Google Scholar 

  • Bullinger M, Kirchberger I, Steinbüchel N (1993) Der Fragebogen All-tagsleben-ein Verfahren zur Erfassung der gesundheitsbezogenen Lebensqualität. Z Med Psychol 3: 121–131

    Google Scholar 

  • Calman KC (1984) Quality of life in cancer patients — a hypothesis. J Med Ethics 10: 124–127

    Article  PubMed  CAS  Google Scholar 

  • Daeppen JB, Krieg MA, Burnand B, Yersin B (1998) MOS-SF-36 in evaluating health-related quality oflife in alcohol-dependent patients. Am J Drug Alcohol Abuse 24: 685–694

    PubMed  CAS  Google Scholar 

  • Degenhardt L, Hall W (2002) Cannabis and psychosis. Curr Psychiatry Rep 4: 191–196

    Article  PubMed  Google Scholar 

  • Franz M, Meyer T, Reber T, Gallhofer B (2000) The importance of social comparisons for high levels of subjective quality of life in chronic schizophrenic patients. Qual Life Res 9: 481–489

    Article  PubMed  CAS  Google Scholar 

  • Heinisch M, Ludwig M, Bullinger M et al (1991) Psychometrische Testung der »Münchner Lebensqualitäts-Dimensionen-liste (MLDL)«. In: Bullinger M, Ludwig M, Steinbüchel N von (Hrsg) Lebensqualität bei kardiovaskulären Erkrankungen. Hogrefe, Göttingen, S 73–91

    Google Scholar 

  • Heinrichs DW, Hanlon TE, Carpenter WTJ (1984) The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 10: 388–398

    PubMed  CAS  Google Scholar 

  • Huppert JD, Smith TE (2001) Longitudinal analysis of subjective quality of life in schizophrenia: anxiety as the best symptom predictor. J Nerv Ment Dis 189(10): 669–75; 189: 669–675

    Article  PubMed  CAS  Google Scholar 

  • Huppert JD, Weiss KA, Lim R, Pratt S, Smith TE (2001) Quality of life in schizophrenia: contributions of anxiety and depression. Schizophr Res 51(2–3); 171–80; 51: 171–180

    Article  PubMed  CAS  Google Scholar 

  • Jones PB, Barnes TR, Davies L et al (2006) Randomized controlled trial of the effect on Quality of Life of second-vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry 63: 1079–1087

    Article  PubMed  CAS  Google Scholar 

  • Kaiser W, Isermann M, Hoffmann K, Huxley P, Priebe S (1999) Short assessment of subjective quality of life. Application and results of a short form of the Berliner Lebensqualltatprofil (BELP-KF). Fortschr Neurol Psychiatr 67: 413–425

    PubMed  CAS  Google Scholar 

  • Karow A, Naber D (2002) Subjective well-being and quality of life under atypical antipsychotic treatment. Psychopharmacology 162: 3–10

    Article  PubMed  CAS  Google Scholar 

  • Karow A, Moritz S, Lambert M, Schoder S, Krausz M (2005) PANSS syndromes and quality of life in schizophrenia. Psychopathology 38: 320–326

    Article  PubMed  CAS  Google Scholar 

  • Karow A, Schnedler D, Naber D (2006) What would the patient choose? Subjective comparison of atypical and typical neuroleptics. Pharmacopsychiatry 39: 47–51

    Article  PubMed  CAS  Google Scholar 

  • Katschnig H (1997) How useful is the concept of quality of life in psychiatry. In: Katschnig H, Freeman H, Sartorius N (eds) Quality of life in mental disorders, 1 st edn. Wiley, Chicester, pp 3–17

    Google Scholar 

  • Katschnig H, Angermeyer MC, Katschnig H, Freeman H, Sartorius N (1997) Quality of life in depression. In: Katschnig H, Freeman H, Sartorius N (eds) Quality of life in mental disorders, 1st edn. Wiley, Chicester, pp 3–17

    Google Scholar 

  • Kennedy SH, Eisfeld BS, Cooke RG (2001) Quality of life: an important dimension in assessing the treatment of depression? J Psychiatry Neurosci 26(Suppl): S23–S28

    PubMed  Google Scholar 

  • Meyer T, Franz M (2002) QLiS — a new schizophrenic-specific quality of life scale. Eur Psychiatry 17(Suppl 1): 184

    Article  Google Scholar 

  • Naber D (1995) A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol 10(Suppl 3): 133–138

    Article  PubMed  Google Scholar 

  • Naber D, Lambert M, Krausz M (2000) Atypische Neuroleptika in der Behandlung schizophrener Patienten, 1. Aufl. UNI-MED, Bremen

    Google Scholar 

  • Naber D, Karow A, Lambert M (2005) Subjective well-being under the neuroleptic treatment and its rele vance for compliance. Acta Psychiatr Scand Suppl: 29–34

    Google Scholar 

  • Perneger TV, Giner F, del Rio M, Mino A (1998) Randomised trial of heroin maintenance programme for addicts who fall in conventional drug treatments. Br Med J 317: 13–18

    CAS  Google Scholar 

  • Pukrop R (2006) For and against: is quality of life a meaningful indicator of outcome? Against. Psychiatr Praxis 33: 314–316

    Google Scholar 

  • Pukrop R, Moller HJ, Sass H et al (1999) Quality of life. Constructvalidation and the development of a modular system. Nervenarzt 70: 41–53

    Article  PubMed  CAS  Google Scholar 

  • VanPutten T (1974) Why do schizophrenic patients refuse to take their drugs? Arch Gen Psychiatry 31: 67–72

    CAS  Google Scholar 

  • Verthein U, Socias CO, Cerda MXM (2000) Quality of life and mental disturbances in opiate addicts. In: Socias CO, Cerda MXM (eds) The 9th annual conference on drug use and drug policy. Universitat de les Illes Balears, Palma, pp 181–195

    Google Scholar 

  • Voruganti L, Cortese L, Oyewumi L, Cernovsky Z, Zirul S, Awad A (2000) Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life. Schizophr Res 43(2–3): 135–145

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Karow, A., Lambert, M., Naber, D. (2008). Lebensqualitätsforschung. In: Holsboer, F., Gründer, G., Benkert, O. (eds) Handbuch der Psychopharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68748-1_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68748-1_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20475-6

  • Online ISBN: 978-3-540-68748-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics